focus -WSS

focus

author：focus 2025-10-02 09:47:18 - browse：3

Senator Ron Wyden (D-OR) speaks with reporters in the Senate subway at the U.S. Capitol — Sen. Ron Wyden (D-Ore.) Drew Angerer/Getty Images

Senate Finance Committee members from both parties took aim Wednesday at insurance brokers that sell plans for large Medicare Advantage insurers.

Older adults at times have more than 100 plan options, and brokers help them choose the right one. But brokers can be incentivized by large insurance companies to aggressively sell plans that are a poor fit for the Medicare beneficiaries they’re supposed to help. Brokers also sometimes collect private information that they sell to multiple insurance companies. Those brokers tend to have a national scope, just like the large insurers they represent, compared to the independent, local brokers.

“They are big private marketing companies in the middle between seniors and their coverage,” Chairman Ron Wyden (D-Ore.) said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Childhood vaccination ad campaign launches in the U.K.

WSS

Virtual repurposing can help discover new uses for existing drugs

Using force crossed my mind when examining a defiant young patient

Using force crossed my mind when examining a defiant young patient

Color Health wants to make cancer screenings convenient

Telehealth options flood the market as retailers push virtual care

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

focus

focus

focus

Virginia high school admissions case could be legal follow

Readout Newsletter: What happened with Sarepta's Duchenne data

Affirmative action in medical school literally saved lives

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Trump demands the U.S. pay no more for drugs than other countries … again

WHO may add ‘noma' to its list of neglected tropical diseases

ChatGPT in medicine: STAT answers readers' burning questions

WHO may add ‘noma' to its list of neglected tropical diseases

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Study fuels hope CAR

Wikipedia

Testing for cancer recurrence creates a new limbo for patients

Senate panel to vote on hospitals, PBMs, prisoner care

Study fuels hope CAR

STAT Madness 2024: Meet the contenders

The pink breast cancer awareness ribbon needs a redesign

Ohio train derailment: Experts on toxic chemical risks

hotspot

hotspot

hotspot

explore